One of the biggest challenges in cancer treatment is chemoresistance: tumors that initially respond well to chemotherapy become resistant over time. When that happens, treatment options are often limited.
Researchers uncover mechanism by which BRCA2-deficient tumors develop chemoresistance
- Post author:admin
- Post published:October 30, 2025
- Post category:uncategorized